We were grateful for the opportunity to attend and present at the AACR Annual Meeting last week, where three of our scientists highlighted some of the exciting work happening in our Vancouver lab.
March 27, 2023
Project ACTT (Access to Cancer Testing and Treatment) in Response to COVID-19 was a joint effort led by Imagia Canexia Health and supported by Digital Supercluster and partner institutions.
July 21, 2022
In this presentation, Dr. Gregory Tranah, of Sutter Health, discusses opportunities and challenges that bringing in-house testing to a large, complex, health system presents. Dr. Tranah will discuss critical success factors for others who are considering embarking on this path.
September 28, 2021
The demand for access to less invasive biopsy methods for cancer presents a critical decision for many provider laboratories.
August 10, 2021
Cancer patients have been heavily impacted by the ongoing COVID-19 pandemic. With thousands of tissue biopsies delayed and patients postponing clinic visits across Canada, increasing access to circulating tumour DNA (ctDNA) testing for targeted treatment selection has offered another option for oncologists.
November 6, 2020
An international panel discuss their experience and insights on maintaining high levels of care for cancer patients, in the midst of a global pandemic, as well as their perspectives on how care may be transformed in the long-term.
April 15, 2020
The demand for access to less invasive biopsy methods for cancer presents a critical decision for many provider laboratories.
Every Imagia Canexia Health report comes with therapeutic recommendations based on specific gene mutations and patient profiles, with clinical trials reviewed and selected by certified clinical molecular geneticists.